The Propeller Digital Therapeutic Platform

Propeller’s FDA-cleared digital therapeutic platform consists of Bluetooth-enabled sensors, a digital patient experience through mobile app or web portal, a clinician insights portal for remote monitoring, plus tailored patient support through virtual coaching. These components seamlessly integrate with one another to improve health outcomes for patients, and in turn, drive measurable clinical and business outcomes for healthcare organizations. Here’s how it works:

1. PropellerConnect™ Sensors & Data Connectivity: Propeller sensors capture unique signals that passively record events, such as medication usage or respiration, and transmit data to Propeller via Bluetooth or hub connection. Sensors are compatible with more than 80% of inhaled medications on the U.S. market, including medications for MDI, Respimat®, Diskus®, Ellipta®, and Symbicort® inhalers.*
2. MyPropeller™ Patient App & Portal: Sensor data is sent to the Propeller mobile app or online portal, empowering patients to learn about their breathing and triggers while delivering personalized, motivating journeys that build healthy habits.
3. PropellerInsight™ Clinical Decision Support & Analytics: Via an EHR integration or our Clinician Portal, care teams can remotely monitor patients’ medication use and view on-demand reports to gain a clearer understanding of disease control status, symptoms, and triggers. These insights help inform clinical decisions and treatment plans, and enable proactive identification of patients who may be at a greater risk for an exacerbation and require timely clinical intervention.
4. PropellerCare™ Support and Coaching: Propeller’s patient success team ensures users receive personalized support and coaching to help them confidently navigate the platform, stay focused on their goals, and take control of their breathing.

Propeller Health Solutions

Propeller configures its digital therapeutic platform into a variety of solutions that help healthcare and life sciences organizations meet their goals while navigating the shift to value-based care.

• For Independent Physician Groups: Remote therapeutic monitoring programs to enhance care for eligible chronic patients
• For Hospitals and Health Systems: Digital health programs for select clinics, target populations, or systemwide; integration into a service line/specialty for population health management
• For Payers and Pharmacy Benefits Managers: Integration of digital health programs into existing care management or population health initiatives
• For Life Sciences Organizations: Integration or co-packaging of digital companion (i.e., sensor, app, support) with connected drug delivery devices such as inhalers to support clinical trials, medication adherence, and biologics

---

*Respimat is a registered trademark of Boehringer Ingelheim Pharmaceuticals, Inc. Diskus and Ellipta are registered trademarks of the GlaxoSmithKline group of companies. Symbicort is a registered trademark of the AstraZeneca group of companies.

Propeller Health is a precision digital health company on a mission to uplift every person living with chronic disease so they can take control of their health and live a better life. We power motivating, care-connected patient journeys and unify value for all stakeholders – providers, health systems, payers, pharmaceutical companies, and other healthcare and life sciences organizations.

The Propeller Platform includes FDA-cleared and CE-marked medical devices, consumer apps, support, and secure access to clinical data for provider monitoring. Our precision approach motivates behavior change and tracks patient adherence that enables medication optimization, helping predict costly exacerbations. We set the scientific standard in digital-first chronic respiratory care through our peer-reviewed research demonstrating improved quality of life and clinical outcomes while lowering healthcare costs.

As a wholly owned subsidiary of ResMed, Propeller brings broad respiratory care expertise, digital therapeutic coverage, and scale globally.

Babyscripts myJourney is a clinically-validated, obstetrics-specific solution that allows OB/GYNs and other maternal health care providers to deliver a new model of prenatal and postpartum care via a mobile app-based platform and remote patient monitoring experiences. It exists to solve the problems generated from the critical shortage of obstetrical providers in the U.S. and to transform the delivery of pregnancy care through the power of technology and remote patient monitoring.

1. Patient users download the Babyscripts myJourney digital companion app onto their smartphone, enabling 24/7 access to personalized educational content tailored to each stage of pregnancy up through one year postpartum.Through myJourney’s assessment and survey functionality, users self-report health history, mental risk, and social determinants of health data. All data is communicated back to the healthcare team through a provider-facing dashboard, enabling the appropriate intervention and facilitating better clinical decision-making. 
2. All users also have access to manual blood pressure tracking in the app, even those who are normotensive or considered low-risk, to support the integration of self monitored blood pressure monitoring into routine prenatal and postpartum care. Patients can input BP data manually or automatically into the myJourney app via a manual or internet-connected cuff. Data is available to the healthcare team through a provider-facing dashboard, and high risk situations are actively communicated to the patient’s healthcare team, enabling recognition of hypertension risk when it occurs and informing any necessary changes to the care plan, including the option to enroll patients onto Babyscripts myJourney Blood Pressure RPM. 

Babyscripts myJourney Blood Pressure RPM is specifically designed for high-risk patients and is supported by a care management layer. Patients track their blood pressure readings at home with the support of a dedicated care manager. Readings are recorded via the myJourney app and an internet or cellular-enabled blood pressure cuff, synced with their healthcare provider's system. This integration allows for continuous monitoring and immediate feedback. If a patient's blood pressure reading is outside of the parameters set by their healthcare team, the app alerts the patient, care manager, and the healthcare team, facilitating timely medical intervention. 

1. Key Components: Babyscripts myJourney Blood Pressure RPM incorporates several key components designed to enhance maternal health outcomes through remote monitoring and patient engagement, including the following: 

• Connected blood pressure cuff: The program provides patients with a digital blood pressure monitor that is internet or cellular-enabled, allowing patients to measure their blood pressure at home and automatically transmit the readings to their healthcare providers in real-time. 
• Mobile app integration: The Babyscripts myJourney app integrates seamlessly with the blood pressure cuff, allowing users to easily log and track their readings. The app is accessible on both smartphones and tablets. 
• Real-time alerts and feedback: The app is programmed to send immediate alerts to patients, care manager, and healthcare providers if any readings fall outside of the parameters set by the healthcare team. By means of a sophisticated exception reporting workflow and the addition of care management support, Babyscripts reduces trigger fatigue, surfacing only actionable data.
• Care management: Patients enrolled onto Babyscripts BP RPM are matched with a care manager, who operates incident to and under the supervision of the healthcare provider to provide education, motivation, and remove any barriers to compliance with daily blood pressure capture.
• Tailored educational content: In addition to general pregnancy and postpartum content, patients enrolled in Babyscripts Blood Pressure RPM receive resources specific to their risk profile. 
• Provider dashboard: Healthcare providers have access to a dedicated dashboard where they can monitor their patients' blood pressure readings, track trends over time, and adjust care plans accordingly. This centralized data collection facilitates better patient management and follow-up care. 
• Patient engagement and compliance tools: The app includes tools to help patients stay engaged and compliant with their monitoring routines. This includes reminders for taking blood pressure readings, educational materials, and motivational content to encourage adherence. The patient’s care manager communicates regularly to ensure compliance. 
• Data security and privacy: The platform complies with all relevant healthcare regulations and standards, including HIPAA, to protect patient information.
• EMR integration: Babyscripts BP RPM integrates into the medical record through several methods, enabling patient onboarding directly in the EMR and automatically filling blood pressure readings into the patient's chart.

Together these components provide a comprehensive solution for managing hypertension in pregnant and postpartum women, significantly improving maternal health outcomes by enabling continuous monitoring and timely medical interventions. The Babyscripts blood pressure RPM model is reimbursable, offering a sustainable service for providers to improve the patient experience and outcomes related to hypertension during pregnancy.

1. Babyscripts partnered with GW-MFA and others in a number of research projects, with results published in ACOG’s Green Journal and JMIR, validating the effectiveness of reduced in-person visits for prenatal care, better management of weight and blood pressure complications, improving compliance and adherence to HEDIS measures, and reducing rates of readmission in the postpartum period through remote monitoring. 
2. Babyscripts' patient-centric solution extends care outside the four walls of the office, making personalized healthcare education, risk-stratified remote monitoring, and real-time virtual triage as readily accessible as the smartphone, responding to mothers’ needs for accessibility and convenience. Babyscripts has deeply engaged this patient population, with 92% of users saying that they would recommend the solution to their friends.
3. Babyscripts' vision for improving care has always been driven and amplified by clinicians: strategic partners like George Washington Medical Faculty Associates, Cone Health System, and Advocate Aurora Healthcare, among others. These partnerships are essential to Babyscripts' project of creating solutions for patients with and for clinicians.
4. Babyscripts gives the healthcare team and payer the ability to monitor both behavioral compliance and physical vital signs between visits, to identify adverse trends in real-time and lower the cost of care. The ability to integrate Babyscripts into the EMR and clinical workflow is one of its most important value-adds, allowing providers to offer comprehensive virtual care and payers and deliver “next generation” care coordination.

Babyscripts is delivering a new model for prenatal and postpartum care that is transforming the way expectant mothers use technology to work with their healthcare providers. Since 2014, Babyscripts has offered the most-implemented mobile clinical solution for remote monitoring in pregnancy, with the mission to eliminate maternal mortality and improve access to care for all mothers. For more information on our virtual care solution and to request a demo, visit babyscripts.com.

To learn about how Propeller differentiates from other options in this space, please reach out to info@propellerhealth.com. 

As a leading precision digital health company, Propeller Health differs from others in the industry in that:  

• Our 10+ FDA and CE cleared devices cover more than 80% of all inhaled medications on the market – and our capabilities go far beyond respiratory care.
• We have conducted 80+ commercial programs and research studies, and a body of research no other digital health company can match: more than 150 peer-reviewed publications and abstracts.
• Our parent company has decades of experience bringing specialized medical devices to market in more than 140 countries. Together, our regulatory expertise, logistics support, engineering and component sourcing knowledge is unmatched.
• We have unique experience partnering with and unifying value for stakeholders across the healthcare ecosystem: independent clinics, hospitals and health systems, payers and PBMs, pharmaceutical and life sciences companies, as well as patients and clinicians. 

---

Our FDA-cleared digital therapeutic platform stands apart from other digital health solutions in that: 

• It is used by a broad spectrum of patients from pediatric (asthma) to elderly (COPD), and is proven effective in engaging underserved and vulnerable patient populations (Medicaid, Medicare). 
• It engages patients with COPD — an often difficult to engage patient population — earlier in their care (stages 1 and 2). For patients whose conditions continue to progress, they can receive care in later stages (3 and 4) with solutions from our parent company, ResMed.

1. Babyscripts has exclusively licensed best-in-class protocols that allow the company to make categorical claims in the market around efficacy and outcomes.
2. The Babyscripts solution has been clinically-validated through peer reviewed research and case studies proving efficacy in schedule optimization, patient engagement, and other outcomes.
3. Babyscripts has a wealth of its own IP in managing patients remotely (like maintaining compliance) and in detecting and triaging abnormal data points to reduce false positives and elevate real problems.
4. While some health systems might invest in specific component parts of what Babyscripts typically offers (an app or integrating data points from IOT devices back to the record), the real challenge is in scaling programs and offering the right protocol at the point of care to generate ROI. Babyscripts is the expert in remote obstetrical care and since 2014 has accumulated a wealth of collateral, assets and best practices that enable these programs to scale.
5. Babyscripts is a scaled program that is significantly less expensive to implement and use than a health system trying to build and maintain their own program. Babyscripts represents a lower cost for health systems to develop, deploy and maintain, with the added benefit of continuous technical and customer support managed by Babyscripts.

1. Babyscripts offers the only clinically-validated, obstetrics-specific mobile platform that delivers educational information that aligns with a provider's care plan. While other maternity programs deliver evidence-based content, only Babyscripts allows the provider to customize their content, delivering the exact information that they want the patient to see and eliminating confusion. 
2. Babyscripts deploys internet-enabled medical devices that directly triage information like high blood pressure back to the physician automatically in their desired workflow, a solution that no consumer app provides. Because of the connection with the provider, Babyscripts detects abnormal trends and then triages those data points directly to the provider’s office. With Babyscripts’ risk-specific modules, a provider is able to deliver different clinical experiences to patients dependent on risk. Babyscripts provides the only clinically-validated solution to focus on obstetrics. 
3. Babyscripts is the first obstetrics-specific digital solution to connect payers and providers, improving care coordination for maternal health populations, monitoring adherence to quality measures, and improving patient engagement and outcomes. This solution helps mothers overcome barriers to care by assessing for risk, providing mothers with direct access to resources directly correlated with their identified risks.